Higher adherence to the MedDiet was associated with a lower risk of BC in postmenopausal females, particularly in ER−/progesterone receptor (PR)− tumors, whereas this correlation was not observed in premenopausal females [23]. This evidence concerns the gene ESR1 and breast cancer.